 | This is a user sandbox of Sulimanir. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. |
Adah Almutairi is a Saudi Arabian scientist who was born in the United States. Her work focuses on nanomedicine, nanotechnology, chemistry and polymer science. She is known for discovering a way in which, a new photon particle could cure and diagnose diseases without the need of a surgery.[1] Almutairi received NIH director’s new innovator award in 2009[2] for her project “Chemically Amplified Response Strategies for Medical Sciences”.[3]
Biography
editEarly life & Education
Almutairi was born in Portland, Oregon, US.[4] She studied high school in Saudi Arabia in the British International School Of Jeddah, before moving to Los Angeles in 1997 to complete her higher education.[5] She graduated from occidental college with a Bachelors degree in chemistry in 2000. She obtained her Ph.D. in materials chemistry from University of California, Riverside, with a focus on electron delocalization and molecular structure in 2005. She also took her Postdoctoral Studies in Chemistry and Chemical Engineering in University of California, Berkeley, from 2005 to 2008.[6] She joined University of California, San Diego in 2008, and has been there ever since, as the director of excellence in Nanomedicine. She is also a member of the departments of NanoEngineering, and Radiology in University of California, San Diego. prior to her move to University of California, San Diego , Almutairi worked with professor Jean Fréchet in University of California, Berkeley to develop several nanoprobes for in vivo imaging.[7]
Contribution
editAlmutairi has contributed throughout her career to Pharmaceutical Sciences. here are some of her contribution:
* Introduced the first polymeric nanoparticle to release drug in response to Concentrations of hydrogen peroxide characteristic of inflammation.
* Developed the first near infrared-degradable polymer, which enables Precise remotely controlled delivery of molecules.
* Created an activatable MRI agent with unprecedented contrast between “on” and “off” states.
*Designed a polymeric nanoparticle that enables delivery to the cytosol by rapid degradation upon exposure to mild acid.[8]
Awards & honors
editAl mutairi has achieved several awards for her contribution to science and medicine including:
NIH director's new innovator Award in 2009.[9]
phRMA foundation award in 2009.
Thiema chemistry journal award in 2009.
Young Investigator Award, World Biomaterials Congress, Chengdu, China in 2012.[10]
Notes
edit- ^ http://ucsdnews.ucsd.edu/feature/whats_new_at_founders_day_2012
- ^ https://commonfund.nih.gov/newinnovator/recipients09
- ^ https://projectreporter.nih.gov/project_info_description.cfm?icde=0&aid=7855815
- ^ Piercey, Judy. "What's New at Founders' Day 2012". ucsdnews.
- ^ http://arabic.arabianbusiness.com/special-reports/352831/19/
- ^ Almutairi, Adah. "Academic achievements/education". pharmacy.ucsd.
- ^ http://almutairi.ucsd.edu/principal-investigator
- ^ Almutairi, Adah. "Key contribution to pharmaceutical science". Pharmacy.ucsd/faculty.
- ^ https://commonfund.nih.gov/newinnovator/recipients09
- ^ Almutairi, Adah. "Academic Achievements/Awards&honors". pharmacy.ucsd.